Production of novel SARS‐CoV‐2 Spike truncations in Chinese hamster ovary cells leads to high expression and binding to antibodies-Reference-Cited by-同舟云学术

Production of novel SARS‐CoV‐2 Spike truncations in Chinese hamster ovary cells leads to high expression and binding to antibodies

Published:2022-06-10 Issue:9 Volume:17 Page:2100678
ISSN:1860-6768
Container-title:Biotechnology Journal
language:en
Short-container-title:Biotechnology Journal

Author:

Minami Shiaki A.¹,Jung Seongwon¹,Huang Yihan²,Harris Bradley S.¹,Kenaston Matthew W.³,Faller Roland¹,Nandi Somen¹⁴,McDonald Karen A.¹⁴,Shah Priya S.¹³^ORCID

Affiliation:

1. Department of Chemical Engineering University of California California Davis USA

2. Department of Materials Science and Engineering University of California California Davis USA

3. Department of Microbiology & Molecular Genetics University of California California Davis USA

4. Global HealthShare Initiative University of California California Davis USA

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biot.202100678

Reference35 articles.

1. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

2. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

3. Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalable bioprocess for the high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells;Process Biochemistry;2024-08

2. All‐in‐one platform: Versatile, Easy, and User‐friendly System (VEUS) based on automated and expert‐independent antibody immobilization and immunoassay by utilizing customized movement of magnetic particles;Biotechnology Journal;2024-06

3. Comparison of vector elements and process conditions in transient and stable suspension HEK293 platforms using SARS-CoV-2 receptor binding domain as a model protein;BMC Biotechnology;2023-03-07